Clinical evaluation of a modified SARS-CoV-2 rapid molecular assay, ID NOW COVID-19 2.0
Description
In the diagnosis of coronavirus disease 2019 (COVID-19), several types of instruments and reagents for SARS-CoV-2 nucleic acid testing have been introduced to meet clinical needs. We evaluated the clinical performances of ID NOW™ COVID-19 2.0 (ID NOW
